Formulation Optimization Case – Dissolution & Dispersion and Trace Impurity Residue Adjustment for Phenoxyethanol

As a new foreign trade service provider driven by technology transformation and foreign trade, HiSiaddi has established a "1+2+3+4=1" service system and can supply phenoxyethanol sourced from multiple well-known original manufacturers.

With strong R&D capabilities, HiSiaddi has repeatedly proposed phenoxyethanol formulation optimization schemes and application improvement recommendations through technological cooperation with manufacturers and accurate market insight. Below is a consulting case of phenoxyethanol formulation optimization delivered by HiSiaddi.

Contact HiSiaddi customer service if you require more formulation optimization consulting services.

I. Client Background & Failure Scenarios (Premium European Beauty End Client, Not Low-End Processor)

This case builds on the successful domestic customized EP pharmacopoeia-grade phenoxyethanol cooperation from Case 1. The client is PARISDERM SAS of Paris, France, a leading listed enterprise specializing in European premium medical wound dressings, sensitive-skin skincare and maternal & infant care products. Its products comply with EP European Pharmacopoeia standards, EU CosIng beauty access rules and EU sensitive-skin low-irritation specifications, supplying medical post-repair dressings used in French public hospitals and premium light luxury skincare brands across Europe.

The client purchases 126 tons of 99.90% high-purity medical beauty-grade phenoxyethanol from HiSiaddi annually, replacing original imported BASF raw materials at a 1:1 ratio for three core high-end formulation systems: alcohol-free sensitive-skin serums, post-operative repair dressings and infant care lotions.

Full physical, chemical and pharmacopoeia indicators of the first 20 tons of domestically customized phenoxyethanol were 100% compliant: purity, free phenol, ethylene glycol residue, heavy metals, water content, microorganisms and chroma all met EP Pharmacopoeia standards, with HPLC spectra and toxicology data fully matching original BASF materials with zero defects on paper.

However, after large-scale replacement of imported raw materials with domestic alternatives for mass production, four fatal mass production defects emerged in premium beauty products – issues undetectable in low-end general cosmetic manufacturing:

1. Insufficient broad-spectrum preservative performance: Micro-mold exceeding standards during long-term paste storage, with weaker bacteriostatic stability than imported materials;

2. Emulsion layer separation and suspended particles: Slight layer separation and white speck suspension observed in high-transparency oil-in-water emulsified serums after 72 hours of static storage;

3. Turbidity after low-temperature storage: Products turn fully turbid after refrigeration at 5°C and cannot recover clarity upon reheating, failing EU beauty constant-temperature storage standards;

4. Increased stinging rate in sensitive-skin patch tests: The originally zero-irritation formulation recorded a jump in human patch test stinging rate from 0.2% to 4.8% after switching to domestic raw materials, failing EU sensitive-skin safety certification.

The client’s internal cosmetic formulators, quality control laboratories and mass production process teams spent 38 days repeatedly adjusting preservative dosage, emulsification rotation speed, homogenization duration, system pH and heating/cooling curves yet failed to eliminate the defects. This delayed filing of new medical dressing products and drastically reduced finished product yield, with large batches of finished goods facing scrapping risks.

The client accurately determined that although macro indicators of domestic phenoxyethanol met standards, micro differences existed versus BASF imported materials in trace hidden impurities, molecular dissolution activity, low-temperature crystallization characteristics and trace irritating by-products. Its 20-year mature formulations developed for imported raw materials could not adapt to the physical properties of domestic alternatives – a high-end cosmetic micro-adaptation problem unsolvable by general traders and conventional cosmetic manufacturers. The client urgently invited HiSiaddi’s fine chemical technical team to conduct special technical research.

II. Four Exclusive High-End Beauty Technical Challenges (Unique to Medical/Sensitive-Skin Formulations, Unnoticeable in Low-End Cosmetics)

All issues stem not from non-compliant raw materials, but micro physical property gaps between domestic refined processes and top-tier BASF imported processes, leading to compatibility failure in high-precision cosmetic systems:

Challenge 1: Trace polar residual impurities passivate preservative molecular activity and weaken synergistic bacteriostatic performance

While total impurities of domestic phenoxyethanol meet standards, trace polar alcohol light fractions remain post rectification. These hidden impurities are not subject to national standard testing requirements yet adsorb and deactivate preservative molecules. The client’s original synergistic preservative system is formulated for inert high-purity BASF materials; switching to domestic raw materials reduces bacteriostatic efficiency, causing mold overgrowth and preservative failure during long-term storage.

Challenge 2: Deviations in molecular dissolution and dispersion disrupt emulsification balance, triggering layer separation and white specks

BASF materials feature highly uniform molecules with consistent polarity; domestic materials have slightly wider micro polarity ranges, leading to insufficient uniform dissolution and dispersion in the client’s high-transparency, lightweight oil-in-water premium emulsified system. Local enrichment occurs after static storage, breaking oil-water phase equilibrium and generating micro white specks and suspended layers.

Challenge 3: Shifted low-temperature crystallization threshold causes irreversible turbidity of high-end formulations under cold conditions

Premium medical skincare products require full transparency and stability between -5°C and 25°C. Domestic phenoxyethanol has different trace isomer distribution compared to imported high-purity materials, shifting low-temperature solubility characteristics. Microcrystals precipitate under cold storage, causing paste turbidity and reduced light transmittance that cannot be reversed by reheating, violating EU premium cosmetic appearance QC standards.

Challenge 4: Trace residual unsaturated components raise irritation for sensitive skin

Domestic processes leave trace ppm-level incompletely reacted phenolic active intermediates (compliant with national standards). These residues have no impact on general cosmetic formulations yet trigger mild irritation in alcohol-free minimalist formulas and systems contacting damaged post-operative skin, directly spiking stinging rates in sensitive-skin patch tests and failing EU low-irritation certification.

III. Root Cause Analysis by HiSiaddi Technical Team

HiSiaddi dispatched a dedicated team of ether synthesis process engineers, EU beauty formulation adaptation specialists and skincare stability analysts. Through spectrum benchmarking of imported vs. domestic raw materials, high-low temperature cycle aging tests, emulsification system replication experiments, human irritation traceability analysis and formulation parameter review, four core root causes were pinpointed:

1. Trace polar light fraction residues in domestic raw materials passivate preservative molecular activity and reduce broad-spectrum bacteriostatic performance;

2. Insufficient molecular polarity uniformity weakens compatibility with premium transparent emulsified systems and disrupts oil-water phase balance;

3. Shifted low-temperature dissolution and crystallization characteristics reduce wide-temperature stability versus imported high-purity materials;

4. Trace active intermediate residues increase irritation potential for minimalist high-end formulations.

IV. Minimally Invasive Full-Dimensional Optimization Solution by HiSiaddi (Zero-Risk Mass Production Adaptation Without Altering Client Core Patented Formulations)

Strictly adhering to the principles of unchanged core formulation ratios, retained original synergistic preservative systems and unmodified EU filing qualifications, HiSiaddi adopted a four-dimensional minimally invasive optimization scheme including deep raw material refining and homogenization, micro synergistic formulation adjustment, reconstructed mass production process curves and standardized warehouse management.

1. Ultimate Post-Production Refining Upgrade for Raw Materials to Eliminate Micro Differences Versus Imported Materials 1:1

HiSiaddi coordinated manufacturers to fully upgrade mass production SOPs for EP pharmacopoeia-grade phenoxyethanol, adding four exclusive refining procedures for premium beauty applications:

1. Add a dedicated low-temperature light fraction removal section to fully strip trace polar light fractions and active intermediate residues, eliminating irritation triggers and restoring preservative molecular activity at the source;

2. Optimize narrow-fraction precision rectification to unify molecular polarity and regularity, improving emulsification system compatibility;

3. Add low-temperature constant-temperature aging and homogenization filtration to standardize low-temperature dissolution properties of batches and eliminate microcrystal precipitation under cold conditions;

4. Implement full-process sterile nitrogen-sealed storage for finished products to strictly control chroma and secondary contamination, achieving full matching of micro physical properties with original BASF materials per batch.

2. Trace Synergistic Preservative Additive Fine-Tuning to Boost Bacteriostatic Performance Without Irritation

After 16 gradient cosmetic formulation lab trials, trace cosmetic-grade ethylhexylglycerin and caprylyl glycol were compounded without altering core client formulations, adding irritating ingredients or impacting filing status:

· Enhance broad-spectrum bacteriostatic performance of phenoxyethanol and stabilize preservative efficacy under high and low temperatures;

· Lower effective raw material dosage thresholds to further reduce potential irritation risks;

· Strengthen oil-water phase compatibility to fully eliminate layer separation and suspended white specks.

3. Reconstruct Exclusive Mass Production Process Curves for Premium Skincare Products

Customized dedicated processes for the client’s three production lines tailored to the dissolution, wetting and dispersion properties of domestic raw materials:

1. Transparent serum system: Optimize low-temperature feeding, slow homogenization and gradient heating processes to guarantee full uniform dissolution of raw materials and avoid local enrichment;

2. Medical dressing system: Adjust preservative addition timing to mid-late emulsification stabilization under low-temperature feeding to maximize retention of preservative activity;

3. Maternal & infant care system: Standardize low-speed stirring and long-duration constant-temperature aging to improve overall system stability.

4. Establish Exclusive Pre-Production Pretreatment Standards for Domestic Raw Materials

1. Uniform constant-temperature warming, sterile homogenization stirring and precision filtration pretreatment for raw materials upon warehouse entry to eliminate micro layering during storage and transportation;

2. Mandatory high-low temperature cycle stability testing, preservative efficacy verification and simulated patch irritation testing for each batch before production, with batches only released for mass production after passing all inspections;

3. Build batch physical property benchmark archives to achieve zero batch fluctuations.

5. Deliver French-English Bilingual Beauty-Grade SOPs and Complete Client Team Training

HiSiaddi issued French-English bilingual standardized operating procedures for cosmetic mass production covering raw material acceptance, pretreatment, feeding processes, emulsification parameters, storage conditions and abnormality troubleshooting, delivering special implementation training for the client’s R&D, production and QA teams.

V. Post-Implementation Improvement Outcomes (All Defects Fully Resolved, Multiple Performance Indicators Surpass Imported Raw Materials)

18 consecutive full-load mass production batches were verified after scheme implementation, with all quantified indicators meeting standards:

1. Fully restored preservative performance: 100% compliance in bacteriostatic rates against mold and bacteria, with superior long-term storage stability versus imported materials;

2. Complete elimination of system defects: Layer separation, suspended white specks and low-temperature turbidity fully resolved, maintaining full transparency and stability across all temperature ranges;

3. Irritation restored to top-tier standards: Sensitive-skin human patch test stinging rate dropped back to 0.18%, outperforming original BASF materials and enabling smooth passage of EU low-irritation certification;

4. Sharply improved mass production yield: Premium medical product yield rose from 88.5% to 99.6%;

5. Significant cost optimization: Combined domestic customization and process loss reduction cut the client’s comprehensive production cost for this skincare line by 17.8%.

VI. Long-Term Cooperation Value

1. The client fully eliminated concerns over domestic premium beauty raw material compatibility, with stable full execution of the 126-ton annual EP-grade phenoxyethanol customized framework contract;

2. The client included HiSiaddi as a pre-R&D cooperation partner for new premium beauty raw materials headquartered in France, entrusting HiSiaddi with pre-process adaptation verification for all localized replacement of premium preservative raw materials;

3. All subsequent raw materials for the client’s organic minimalist skincare and children’s zero-irritation care new product lines are exclusively customized and technically supported by HiSiaddi.

VII. Core Case Summary

Core logic for premium beauty products: Physical and chemical compliance ≠ formulation compatibility. Medical, sensitive-skin and maternal & infant high-end formulations are extremely sensitive to raw material micro impurity distribution, molecular uniformity, low-temperature physical properties and potential irritation. General national and pharmacopoeia macro indicators only serve as entry thresholds. Trace hidden physical property discrepancies are the core cause of formulation failure, excessive irritation and system instability – blind spots unidentifiable by conventional manufacturers and low-end traders.

HiSiaddi’s core differentiated value extends beyond supplying customized premium raw materials: it provides a full technical closed loop covering fine daily chemical synthesis mechanisms, premium beauty formulation adaptation, cosmetic mass production process optimization and safety stability control, bridging compatibility gaps between domestic raw materials and top-tier European premium cosmetic precision manufacturing processes.

Core rigid demands of European and American premium beauty clients: zero irritation, system compatibility, wide-temperature stability and long-term safe preservative performance. Extreme full-process technical after-sales support forms the core barrier for long-term binding of mid-to-high-end clients, far outweighing low unit prices.

Contact HiSiaddi customer service for more formulation optimization consulting services.